메뉴 건너뛰기




Volumn 95, Issue 12, 2010, Pages 2119-2125

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

(14)  Gupta, Vikas a   Eapen, Mary b   Brazauskas, Ruta b   Carreras, Jeanette b   Aljurf, Mahmoud c   Gale, Robert Peter d   Hale, Gregory A e   Ilhan, Osman f   Passweg, Jakob R g   Ringdén, Ollé h   Sabloff, Mitchell i   Schrezenmeier, Hubert j   Socié, Gerard k   Marsh, Judith C W l  


Author keywords

HLA identical sibling donor; Overall survival; Patient age; Severe aplastic anemia; Transplantation

Indexed keywords

BUSULFAN; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; FLUDARABINE; METHOTREXATE; THYMOCYTE ANTIBODY;

EID: 78649932299     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.026682     Document Type: Article
Times cited : (129)

References (26)
  • 2
    • 33750628439 scopus 로고    scopus 로고
    • Current concepts in the pathophysiology and treatment of aplastic anemia
    • Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108(8):2509-19.
    • (2006) Blood , vol.108 , Issue.8 , pp. 2509-2519
    • Young, N.S.1    Calado, R.T.2    Scheinberg, P.3
  • 3
    • 0031030329 scopus 로고    scopus 로고
    • Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle bone marrow transplant team
    • Doney K, Leisenring W, Storb R, Appelbaum FR. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team. Ann Intern Med. 1997; 126(2):107-15.
    • (1997) Ann Intern Med , vol.126 , Issue.2 , pp. 107-115
    • Doney, K.1    Leisenring, W.2    Storb, R.3    Appelbaum, F.R.4
  • 4
    • 78649910213 scopus 로고    scopus 로고
    • Acquired aplastic anemia and Fanconi anemia
    • In: Barrett J, Trealeaven J, editors
    • Gupta V, Marsh J. Acquired aplastic anemia and Fanconi anemia. In: Barrett J, Trealeaven J, editors. Practical Stem Cell Transplantation. 2009;165-77.
    • (2009) Practical Stem Cell Transplantation , pp. 165-177
    • Gupta, V.1    Marsh, J.2
  • 5
    • 58149090759 scopus 로고    scopus 로고
    • Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia
    • Scheinberg P, Wu CO, Nunez O, Young NS. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol. 2009;144(2):206-16.
    • (2009) Br J Haematol , vol.144 , Issue.2 , pp. 206-216
    • Scheinberg, P.1    Wu, C.O.2    Nunez, O.3    Young, N.S.4
  • 6
    • 50549104303 scopus 로고    scopus 로고
    • Treatment strategies for patients with severe aplastic anemia
    • Bacigalupo A. Treatment strategies for patients with severe aplastic anemia. Bone Marrow Transplant. 2008;42 (Suppl 1):S42-4.
    • (2008) Bone Marrow Transplant , vol.42 , Issue.1 SUPPL. , pp. 42-44
    • Bacigalupo, A.1
  • 8
    • 12944332070 scopus 로고    scopus 로고
    • Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy - the European Group for Blood and Marrow Transplantation experience
    • Bacigalupo A, Brand R, Oneto R, Bruno B, Socie G, Passweg J, et al. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy - the European Group for Blood and Marrow Transplantation experience. Semin Hematol. 2000;37(1):69-80.
    • (2000) Semin Hematol , vol.37 , Issue.1 , pp. 69-80
    • Bacigalupo, A.1    Brand, R.2    Oneto, R.3    Bruno, B.4    Socie, G.5    Passweg, J.6
  • 9
    • 17444452424 scopus 로고    scopus 로고
    • Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the european group for blood and marrow transplantation. on behalf of the working party on severe aplastic anemia of the European group for blood and marrow transplantation
    • Bacigalupo A, Oneto R, Bruno B, Socie G, Passweg J, Locasciulli A, et al. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation. Acta Haematol. 2000;103(1):19-25.
    • (2000) Acta Haematol , vol.103 , Issue.1 , pp. 19-25
    • Bacigalupo, A.1    Oneto, R.2    Bruno, B.3    Socie, G.4    Passweg, J.5    Locasciulli, A.6
  • 10
    • 12144289116 scopus 로고    scopus 로고
    • Long-term outcome after bone marrow transplantation for severe aplastic anemia
    • Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood. 2004;103(7): 2490-7.
    • (2004) Blood , vol.103 , Issue.7 , pp. 2490-2497
    • Ades, L.1    Mary, J.Y.2    Robin, M.3    Ferry, C.4    Porcher, R.5    Esperou, H.6
  • 11
    • 33846898991 scopus 로고    scopus 로고
    • Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: A report from the European Group for Blood and Marrow Transplantation (EBMT)
    • Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A, et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2007;92(1):11-8.
    • (2007) Haematologica , vol.92 , Issue.1 , pp. 11-18
    • Locasciulli, A.1    Oneto, R.2    Bacigalupo, A.3    Socie, G.4    Korthof, E.5    Bekassy, A.6
  • 12
    • 70349148649 scopus 로고    scopus 로고
    • Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabinebased conditioning: A comparison with conventional conditioning regimen
    • Maury S, Bacigalupo A, Anderlini P, Aljurf M, Marsh J, Socie G, et al. Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabinebased conditioning: a comparison with conventional conditioning regimen. Haematologica. 2009;94(9):1312-5.
    • (2009) Haematologica , vol.94 , Issue.9 , pp. 1312-1315
    • Maury, S.1    Bacigalupo, A.2    Anderlini, P.3    Aljurf, M.4    Marsh, J.5    Socie, G.6
  • 13
    • 48949116752 scopus 로고    scopus 로고
    • Graft-versushost disease following marrow transplantation for aplastic anemia: Different impact of two GVHD prevention strategies
    • Siegal D, Xu W, Sutherland R, Kamel-Reid S, Kuruvilla J, Lipton JH, et al. Graft-versushost disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies. Bone Marrow Transplant. 2008;42(1):51-6.
    • (2008) Bone Marrow Transplant , vol.42 , Issue.1 , pp. 51-56
    • Siegal, D.1    Xu, W.2    Sutherland, R.3    Kamel-Reid, S.4    Kuruvilla, J.5    Lipton, J.H.6
  • 14
    • 10344221138 scopus 로고    scopus 로고
    • Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti- CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia
    • Gupta V, Ball SE, Yi QL, Sage D, McCann SR, Lawler M, et al. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti- CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Biol Blood Marrow Transplant. 2004;10(12): 867-76.
    • (2004) Biol Blood Marrow Transplant , vol.10 , Issue.12 , pp. 867-876
    • Gupta, V.1    Ball, S.E.2    Yi, Q.L.3    Sage, D.4    McCann, S.R.5    Lawler, M.6
  • 17
    • 0033616908 scopus 로고    scopus 로고
    • Estimation of failure probabilities in the presence of competing risks: New representations of old estimators
    • Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;30;18(6):695-706.
    • (1999) Stat Med , vol.18-30 , Issue.6 , pp. 695-706
    • Gooley, T.A.1    Leisenring, W.2    Crowley, J.3    Storer, B.E.4
  • 19
    • 0037420270 scopus 로고    scopus 로고
    • Antithymocyte globulin and cyclosporine for severe aplastic anemia: Association between hematologic response and long-term outcome
    • Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003; 289(9):1130-5.
    • (2003) JAMA , vol.289 , Issue.9 , pp. 1130-1135
    • Rosenfeld, S.1    Follmann, D.2    Nunez, O.3    Young, N.S.4
  • 20
    • 0037441586 scopus 로고    scopus 로고
    • Antithymocyte globulin with or without cyclosporin A: 11-year follow- up of a randomized trial comparing treatments of aplastic anemia
    • Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H. Antithymocyte globulin with or without cyclosporin A: 11-year follow- up of a randomized trial comparing treatments of aplastic anemia. Blood. 2003;101(4):1236-42.
    • (2003) Blood , vol.101 , Issue.4 , pp. 1236-1242
    • Frickhofen, N.1    Heimpel, H.2    Kaltwasser, J.P.3    Schrezenmeier, H.4
  • 21
    • 0027360514 scopus 로고
    • Malignant tumors occurring after treatment of aplastic anemia. European bone marrow transplantation-severe aplastic anaemia working party
    • Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993; 329(16):1152-7.
    • (1993) N Engl J Med , vol.329 , Issue.16 , pp. 1152-1157
    • Socie, G.1    Henry-Amar, M.2    Bacigalupo, A.3    Hows, J.4    Tichelli, A.5    Ljungman, P.6
  • 22
    • 15544377256 scopus 로고    scopus 로고
    • Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning
    • Gupta V, Ball SE, Sage D, Ortin M, Freires M, Gordon-Smith EC, et al. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant. 2005;35(5):467-71.
    • (2005) Bone Marrow Transplant , vol.35 , Issue.5 , pp. 467-471
    • Gupta, V.1    Ball, S.E.2    Sage, D.3    Ortin, M.4    Freires, M.5    Gordon-Smith, E.C.6
  • 23
    • 34347375339 scopus 로고    scopus 로고
    • Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia
    • George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia. Bone Marrow Transplant. 2007;40(1):13-8.
    • (2007) Bone Marrow Transplant , vol.40 , Issue.1 , pp. 13-18
    • George, B.1    Mathews, V.2    Viswabandya, A.3    Kavitha, M.L.4    Srivastava, A.5    Chandy, M.6
  • 24
    • 10744233646 scopus 로고    scopus 로고
    • Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection
    • Dulley FL, Vigorito AC, Aranha FJ, Sturaro D, Ruiz MA, Saboya R, et al. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection. Bone Marrow Transplant. 2004;33(1):9-13.
    • (2004) Bone Marrow Transplant , vol.33 , Issue.1 , pp. 9-13
    • Dulley, F.L.1    Vigorito, A.C.2    Aranha, F.J.3    Sturaro, D.4    Ruiz, M.A.5    Saboya, R.6
  • 25
    • 33646671932 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine- based preparative regimen
    • Resnick IB, Aker M, Shapira MY, Tsirigotis PD, Bitan M, Abdul-Hai A, et al. Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine- based preparative regimen. Br J Haematol. 2006;133(6):649-54.
    • (2006) Br J Haematol , vol.133 , Issue.6 , pp. 649-654
    • Resnick, I.B.1    Aker, M.2    Shapira, M.Y.3    Tsirigotis, P.D.4    Bitan, M.5    Abdul-Hai, A.6
  • 26
    • 0033168009 scopus 로고    scopus 로고
    • Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry
    • Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341(1):14-21.
    • (1999) N Engl J Med , vol.341 , Issue.1 , pp. 14-21
    • Socie, G.1    Stone, J.V.2    Wingard, J.R.3    Weisdorf, D.4    Henslee-Downey, P.J.5    Bredeson, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.